Clinical Trial Update: Duloxetine vs. Active Comparator in the Treatment of Patients With Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing duloxetine with an active comparator in patients with depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depression | Phase 4 | Status: COMPLETED